COMMUNIQUÉS West-GlobeNewswire

-
Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025
20/10/2025 -
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director
20/10/2025 -
IMUNON Hosts R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer
20/10/2025 -
Akebia Therapeutics Announces Five Presentations at ASN Kidney Week 2025
20/10/2025 -
Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025
20/10/2025 -
Clene to Present at the Emerging Growth Conference
20/10/2025 -
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
20/10/2025 -
NewGen Announces Strategic Entry into Art Tokenization Market with $2 Million Private Collection Deal, Expandable to $200 Million
20/10/2025 -
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
20/10/2025 -
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
20/10/2025 -
EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU
20/10/2025 -
Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib
20/10/2025 -
SARMs RAD 140 (Testolone) and IBUTAMOREN MK-677 SARMS Stack: Crazy Bulk Lunch Rad 140 Effective Sarms for Bulking and Muscle Growth in 2025
20/10/2025 -
Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn’s Disease (FSCD)
20/10/2025 -
OneMedNet Welcomes Our Latest Subscriber mlHealth360
20/10/2025 -
AAMI and TechNation Collaborate to Survey HTM Field
20/10/2025 -
Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials
20/10/2025 -
VitalHub Announces Q3 2025 Conference Call Date
20/10/2025 -
ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025
20/10/2025
Pages